SCHEMBL1102340

SCHEMBL1102340

CCCCCCCCc1ccc(-c2ccc(-c3cccs3)s2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.45
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 4/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
DPP4 P27487 3/20 0.43
HSD17B10 Q99714 2/20 0.43
TSHR P16473 1/20 0.43
LMNA P02545 3/20 0.42
ESR1 P03372 2/20 0.42
ADRA2A P08913 2/20 0.42
ADORA3 P0DMS8 2/20 0.42
TACR2 P21452 2/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
SHBG P04278 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
HSPD1 P10809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15070057 1.00 LTA4H (0.45) LTA4HKDM4EALDH1A1RAB9ANPC1
SCHEMBL1102349 0.90 LTA4H (0.56) LTA4HKDM4EALDH1A1RAB9AHSD17B10
SCHEMBL6417507 0.90 LTA4H (0.56) LTA4HKDM4EALDH1A1RAB9AHSD17B10
SCHEMBL15071803 0.90 LTA4H (0.56) LTA4HKDM4EALDH1A1RAB9AHSD17B10
SCHEMBL6422261 0.88 HSD17B10 (0.53) KDM4EALDH1A1RAB9AHSD17B10TSHR
SCHEMBL6421748 0.88 HSD17B10 (0.53) KDM4EALDH1A1RAB9AHSD17B10TSHR
SCHEMBL1231095 0.88 HSD17B10 (0.53) KDM4EALDH1A1RAB9AHSD17B10TSHR
SCHEMBL4449126 0.88 HSD17B10 (0.53) KDM4EALDH1A1RAB9AHSD17B10TSHR
SCHEMBL14703081 0.86 HSD17B10 (0.56) KDM4EALDH1A1RAB9AHSD17B10TSHR
SCHEMBL2466020 0.86 HSD17B10 (0.55) KDM4EALDH1A1RAB9AHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716703-B2 Organic semiconductor transistor FUJI XEROX CO., LTD. (JP) 2014-05-06 US disclosed
US-20130161589-A1 ORGANIC SEMICONDUCTOR TRANSISTOR FUJI XEROX CO., LTD. (JP) 2013-06-27 US disclosed
US-8153822-B2 Fluorene compound FUJI XEROX CO., LTD. (JP) 2012-04-10 US disclosed
US-20100197942-A1 NOVEL FLUORENE COMPOUND FUJI XEROX CO., LTD. (JP) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197942-A1 NOVEL FLUORENE COMPOUND AFF1, AFF2, FLI1 LTA4H 3990/4885KDM4E 4551/4885ALDH1A1 1090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.